Aronex Pharma (ARNX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aronex Pharma (ARNX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: GregSL who wrote (311)	10/9/1999 9:13:00 PM
From: Sam Lee	Read Replies (1) of 320

This game is not over. I have sold not a share. Maybe I am just a blind optimist, but there are a couple of thousand or so people out there who need atragen to live. The drug seems to work. So that is a persuasive argument to my way of thinking. We had a disappointing round, but we are by no means out of the fight. IMHO. And if you think that the company's recent announcement re rights and takeover is just made out of boredom then think again. A suitor could pick up about $1.25 a share in remaining milestone payments plus our royalty on nyotran, all of which makes a purchase cheaper than the actual offering price, if any. IMHO. Just a Saturday night thought.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next